VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses

Published 2015 View Full Article

Authors

Keywords

Experimental autoimmune encephalomyelitis, Neuroimmunology, Autoimmunity, Inflammation, Neuropeptide, VPAC2 receptor, Regulatory T cell

Journal

BRAIN BEHAVIOR AND IMMUNITY

Volume 44, Issue -, Pages 167-175

Publisher

Elsevier BV

Online

2014-10-14

DOI

10.1016/j.bbi.2014.09.020

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started